Richard Blidner

Title: The Innovative Contributions of Richard Blidner

Introduction

Richard Blidner is a notable inventor based in Glenview, IL (US), recognized for his significant contributions to the field of next-generation sequencing and immunology. With a total of four patents to his name, Blidner has developed innovative systems and methods that enhance the efficiency and accuracy of genetic profiling.

Latest Patents

Among his latest patents, one focuses on "Systems and methods for next generation sequencing uniform probe design." This patent outlines a method for optimizing a set of probes by assessing their recovery rates against a sample library. The process involves modifying the concentration of probes that do not meet predetermined recovery rate thresholds and reevaluating the set until an optimized probe set is achieved.

Another significant patent is titled "TCR/BCR profiling using enrichment with pools of capture probes." This disclosure presents systems and methods for profiling T cell receptor (TCR) and B cell receptor (BCR) repertoires using next-generation sequencing methods. It also addresses the potential for diagnosing and predicting medical conditions based on TCR/BCR profile data.

Career Highlights

Richard Blidner has worked with prominent companies in the biotechnology sector, including Tempus Labs, Inc. and Tempus AI, Inc. His work in these organizations has contributed to advancements in genomic research and personalized medicine.

Collaborations

Throughout his career, Blidner has collaborated with talented professionals, including Jason Perera and Taylor Harding. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Richard Blidner's innovative work in next-generation sequencing and immunology has made a significant impact on the field. His patents reflect a commitment to advancing genetic research and improving diagnostic methods.